This independent HPLC lab test confirms Retatrutide 10mg from Research Peptides Europe at >99.8% purity. The analysis was conducted by Liquilabs on September 25, 2025.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for weight management, metabolic regulation, and glycemic control. A purity level exceeding 99.8% indicates minimal contamination and high-grade synthesis.
Endotoxin testing shows < 0.001 EU/mg, confirming low bacterial contamination. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.